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Total hip arthroplasty versus
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older adults with intracapsular hip fractures
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Abstract
Background: Displaced intracapsular hip fractures are typically treated with hemiarthroplasty (HA) or total hip
arthroplasty (THA). A number of professional bodies recommend considering THA for patients that were
independently mobile and cognitively intact before injury. The aim of this study was to compare the outcomes
between HA and THA for independently mobile older adults with hip fractures.
Methods: A systematic review and meta-analysis of RCTs was undertaken alongside analysis of a propensity score
matched national cohort of older adults (aged > 60) with hip fractures. Participants were identified for the
propensity score matched cohort from the National Hip Fracture Database (NHFD), which was linked to Hospital
Episode Statistics (HES) and civil death registration data. The primary outcomes were 12-month dislocation, revision,
and mortality. The secondary outcomes were length of stay, discharge home, unplanned re-admission, functional
outcomes, and health-related quality of life.
Results: Five RCTs reported higher THA dislocation but this was not statistically significant (THA risk ratio [RR] 2.77,
95% CI 0.81 to 9.48). However, THA dislocation was significantly higher in the national observational dataset
(sub-distribution hazard ratio [SHR] 1.73, 95% CI 1.24 to 2.41). Meta-analysis of data from four RCTs did not identify a
significant difference in terms of revision (RR 1.52, 95% CI 0.56 to 4.14). However, THA revision was significantly
lower in the national dataset (SHR 0.66, 95% CI 0.48 to 0.90). Meta-analysis of data from 5 RCTs suggested higher
mortality amongst patients undergoing HA (RR 0.63, 95% CI 0.38 to 1.04), which was also observed within the
national registry dataset (hazard ratio 0.45, 95% CI 0.37 to 0.54).
Conclusions: National clinical registries can provide important context when interpreting RCT data, which may
alone be inadequate for comparing the safety profile of surgical interventions. These data suggest that THA is at
significantly higher risk of dislocation but lower risk of revision within 12 months. The finding from both RCT and
clinical registry data that THA is associated with lower 12-month mortality amongst the fittest patients with hip
fractures requires urgent further study to determine whether or not this can be replicated in other balanced
populations.
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Background
There are 70,000 hip fractures every year in the United
Kingdom, with the total cost of care exceeding £2 billion
per year. Mortality is high amongst these patients, with
approximately 10% dying within 30 days of admission [1]
and 30% within a year. Many survivors are unable to
continue living independently and 4.5 million people
worldwide are disabled every year by a hip fracture2.
Most intracapsular hip fractures are displaced, such
that the bone fragments are no longer in continuity. Dis-
placed intracapsular fractures are either treated with hip
hemiarthroplasty (HA), where the femoral head alone is
replaced, or total hip arthroplasty (THA), where the
femoral head and acetabulum are both replaced. Al-
though HA is performed more frequently, a number of
organisations (such as the American Academy of Ortho-
paedic Surgeons [AAOS] [2] and the UK National Insti-
tute for Health and Care Excellence [NICE] [3])
recommend offering THA to selected hip fracture pa-
tients owing to perceived functional benefits. NICE rec-
ommends offering THA to patients that (1) could walk
independently before the fracture (2) are not cognitively
impaired and (3) are medically fit for both anaesthesia
and the procedure [3]. Despite this recommendation, an
international survey of orthopaedic surgeons found that
73% favour HA [4], with studies demonstrating less than
a third of eligible patients actually receive THA [5]. One
explanation for this discrepancy is that the evidence in
support of THA is mixed. A number of small rando-
mised controlled trials have suggested that THA is asso-
ciated with better functional outcomes, fewer wound
infections, and reduced need for secondary procedures
[6–9]. However, THA is also a more complex procedure
that requires longer surgical time, is associated with
greater blood loss, and has a higher risk of subsequent
dislocation [10].
It is also uncertain whether the reported benefits for
THA over HA [6–9] can be replicated beyond the con-
trolled environment of clinical trials. For example, there is
a clear association between THA outcome and surgeon
volume [11] and it is likely that patients will be preferen-
tially recruited to THA trials by experienced arthroplasty
surgeons. It has been suggested that increasing the num-
ber of generalist surgeons providing THA will offset the
benefits of this intervention for patients with hip fractures
[2]. Similarly, there are concerns that the unavailability of
appropriately trained arthroplasty surgeons might delay
operative treatment. Surgical delays are thought to worsen
outcomes for this vulnerable patient group [12, 13] and so
might even worsen outcomes for patients selected to
undergo THA. It is for these reasons that the “real world”
effect of increasing use of THA in the hip fracture setting
has been identified as a hip fracture research recommen-
dation by the AAOS [2].
In this study we undertook an updated meta-analysis
of RCTs and used data from a comprehensive national
cohort of hip fractures to provide “real world” context to
the existing trial literature. Our aim was to compare the
outcomes between these two procedures for independ-
ently mobile older adults with hip fractures.
Methods
Systematic review and meta-analysis
A scoping review identified a number of previous system-
atic reviews that compared HA and THA for patients with
displaced intracapsular hip fractures. We therefore
employed a simplified search strategy using a modification
of the method first proposed by Sampson et al. [14], which
has been shown to be highly sensitive (median sensitivity
100%) for identifying RCTs when applied to systematic re-
views with clinically focussed research questions [15]. We
used a broad search strategy: (fracture* AND (“total hip”
OR hemiarthroplasty) AND “systematic review”) to search
three databases (Medline 1966-, EMBASE 1947-, and
CINAHL 1982-) on 1st August 2018 to identify previous
systematic reviews comparing HA and THA. The refer-
ence lists of all reviews were searched and the forward cit-
ation facility in PubMed used to identify trials published
after each systematic review. Trial reference lists and cita-
tions were also searched for further studies. No language
restrictions were applied. The full texts of all RCTs were
then screened by two authors (DM and CZ) to identify
those satisfying the following inclusion criteria. A single
author (DM) evaluated studies published in Chinese with
help from a Chinese-speaking health economist with ex-
perience of hip fracture research. The inclusion criteria
were:
 A randomised or quasi-randomised controlled trial.
 Including patients predominantly aged > 60 years
with displaced intracapsular hip fractures.
 Excluding patients that had cognitive impairment or
limited mobility before injury.
 Reporting dislocation, revision, mortality, unplanned
re-admission, functional outcomes or health-related
quality of life (using any validated scale).
Study characteristics and outcome data were extracted
by one author (DM) and checked by a second (CZ). We
planned to report all outcomes at 12-months for
consistency. Two authors (DM and CZ) independently
determined risk of bias using criteria recommended by
the Cochrane Handbook [16] and resolved disagreements
by consensus. These data were presented to guide judge-
ments about the certainty of the evidence and not to de-
termine eligibility for inclusion within meta-analyses. Data
were pooled to estimate risk ratios (for categorical out-
comes) and mean differences (for continuous outcomes)
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using the DerSimonian and Laird method for
random-effects meta-analysis as high levels of
between-study heterogeneity were anticipated when pool-
ing trials from different patient populations and healthcare
settings [17]. Standardised mean differences were reported
when studies reported the same outcome measured on
difference scales. When studies did not provide standard
deviations necessary to inform confidence intervals, these
were calculated from absolute p-values [16].
Meta-analyses were undertaken using RevMan v.5.0
(Cochrane Collaboration, Vienna, Austria). The systematic
review was reported in line with the Preferred Reporting
Items for Systematic Reviews and Meta-Analyses
(PRISMA) statement [18] and the protocol registered pro-
spectively in the PROSPERO database with reference
CRD42018109415 [19].
Observational “real world” data
An observational study was undertaken using a compre-
hensive national cohort of older adults with displaced
intracapsular hip fractures to extend and contextualise the
existing RCT literature. Propensity score matching was
used to mimic randomisation as far as is possible using
observational data.
Data sources
The cohort was defined using the National Hip Fracture
Database (NHFD) and patient records linked to adminis-
trative data (Hospital Episode Statistics) and civil death
registrations.
National hip Fracture Database The National Hip Frac-
ture Database (NHFD) is the largest hip fracture registry in
the world. It is commissioned by the Healthcare Quality
Improvement Partnership (HQIP) and captures data on al-
most all (> 95%) adults that are aged > 60 years and admit-
ted to hospital in England, Wales, or Northern Ireland with
a proximal femoral fracture [20]. There were 177 hospitals
contributing data to the NHFD in 2016 [21]. Data are col-
lected by specialist nurses in each hospital and submitted
through an online platform. Submissions are linked to hos-
pital payments through the Hip Fracture Best Practice Tariff
and so completeness of core variables is high.
Hospital episode statistics The Hospital Episode Statis-
tics Admitted Patient Care (HES APC) dataset includes
data on all admissions to National Health Service (NHS)
hospitals or to independent sector providers that are
funded by the NHS [22]. Approximately 99% of hospital
activity in England is funded by the NHS [23] and so
should be included within the HES APC. All activities
are included that require a hospital bed (e.g. planned
and emergency admissions) but outpatient and Emer-
gency Department are excluded unless they lead to
admission. The dataset includes approximately 20 mil-
lion episodes of care annually from around 450 individ-
ual NHS organisations [22].
Office for National Statistics The Office for National
Statistics (ONS) captures data (including date and cause)
on all registered deaths directly from civil registration
records [24]. This dataset should therefore be complete
except for the small number of cases referred to a cor-
oner, which cannot be registered until coronial enquiries
are complete and a death certificate has been issued.
Study population
The study period was 28th March 2011 until 4th January
2017. The start date was the earliest point at which the
NHFD captured unique patient identifiers that could fa-
cilitate linkage to other datasets and the end date was
chosen to facilitate 12 months follow-up. The inclusion
criteria were those recommended by NICE [3]:
 All adults aged > 60.
 Displaced fracture of the femoral neck that was
deemed unsuitable for internal fixation.
 Independently mobile or using a single stick before
injury.
 Medically fit to undergo hip arthroplasty, defined as
an American Society of Anaesthesiologists [ASA]
grade < 2 [5].
 Patients without substantial cognitive impairment,
defined as an Abbreviated Mental Test Score
(AMTS) > 8 [5].
We excluded patients that presented to hospitals in
Wales, Northern Ireland, and the Isle of Man as HES
APC only captures data from hospitals in England. Cases
were also excluded if they could not be positively
matched to records within HES APC based on their
NHS number, sex, date of birth, and full post-code.
Outcomes
The primary outcomes were dislocation, revision, and
mortality within 12-months. The secondary outcomes
were surgical delay, length of stay, discharge to own
home, and re-admission within 30 days. Surgical delay,
length of stay, and discharge destination were avail-
able directly from the NHFD. Revision operations
were identified from HES APC and defined by OPCS
v4 (OPCS4) procedure codes previously used in other
studies and incorporating codes recommended for this
purpose by the UK National Joint Registry [25] (Add-
itional file 1). Dislocation OPCS4 codes were identi-
fied by manual searches using disloc*, manipula*, and
reduc* (Additional file 1).
Metcalfe et al. BMC Musculoskeletal Disorders          (2019) 20:226 Page 3 of 11
Statistical analysis
Matching We calculated propensity scores that repre-
sented the estimated probability of each patient under-
going THA based on characteristics that are known to
be associated with outcome in this population: age, sex,
pre-injury mobility status, admission source, American
Society of Anaesthesiologists (ASA) physical status
grade, Charlson Co-morbidity Index (Additional file 1),
Abbreviated Mental Test Score (AMTS), and Index of
Multiple Deprivation (IMD) [26]. The model was other-
wise specified iteratively to achieve the best possible
match, as judged by visual inspection of the distribution
of propensity scores after matching and plots of
co-variables against propensity scores by treatment sta-
tus. We also undertook post-estimation statistical checks
[27], which included t-tests for differences in means and
confirmation that the standardised mean difference for
each co-variable between the groups was < 1% [28]. The
final model utilised 1:1 nearest neighbour matching with
a 0.02 calliper (as recommended by Austin [29]), no re-
placement, and the common support restriction. All
subsequent descriptive, regression, and survival analyses
were confined to the propensity score matched groups.
Descriptive statistics Categorical variables were com-
pared using Chi-square tests and non-normally distrib-
uted continuous variables using the Kruskall-Wallis
one-way analysis of variance test. Length of stay data
were only analysed for the proportion of patients that
were discharged alive from hospital to prevent left skew
caused by early deaths.
Survival analysis Kaplan-Meier estimates were plotted
with 95% confidence intervals for cumulative survival
free from unplanned secondary procedures. The pro-
portional hazards assumption was tested by visual
examination and statistical assessment of the relation-
ship between event time and Schoenfeld residuals.
The proportional hazards assumption was satisfied
and so we used Cox regression models fitted with our
primary outcome (dislocation and/or revision) as the
independent variable. Mortality is high in this popula-
tion and so we undertook a sensitivity analysis using
competing risks regression models with death speci-
fied as the competing risk. Competing risks regression
models were also fitted for dislocation and revision as
individual events. The co-variables for all regression
models were those described above as the basis for
propensity score matching, which include five of the
six used routinely in the NHFD for case mix adjust-
ment [30]. The sixth NHFD case mix co-variable (i.e.
fracture type) was not used because only patients
with displaced intracapsular hip fractures were
included in this study. Year of fracture was included
as an ordinal variable within regression models to ac-
count for the possibility of changing outcomes over
time.
Multivariable regression Multivariable logistic regres-
sion was used to adjust for residual imbalance between
the two groups in respect of discharge to own home and
30-day re-admission. The co-variables were as specified
above. Length of stay data conformed to a gamma distri-
bution and so were adjusted using generalized linear
models (GLM) together with post-estimation calcula-
tions of average marginal effects to yield predicted mean
differences and 95% confidence intervals. Logistic re-
gression and GLMs utilised cluster-robust standard er-
rors and robust variance estimators [31] to account for
the lack of independence between matched records [32].
Propensity score matching was achieved using the
MatchIt application for R (R Foundation for Statistical
Computing, Vienna, Austria). All subsequent analyses
were undertaken using StataIC v.15 (StataCorp, College
Station, TX, USA). Two tailed p < 0.05 was adopted a
priori as the threshold for statistical significance.
Results
Meta-analysis of randomised trials
There were 11 previous systematic reviews but none re-
ported analyses limited to patients that were cognitively
intact and independently mobile before injury (Additional
file 2: Figure S1). The 11 earlier reviews included 16 trial
reports, which presented data from 14 individual RCTs.
Eight RCTs did not satisfy the restricted inclusion criteria
of this systematic review, e.g. they did not exclude patients
with cognitive impairment or limited mobility. One study
could not be retrieved despite extensive attempts. The rea-
sons for excluding each RCT are shown in Additional file
2: Table S1. Five randomised controlled trials satisfied the
eligibility criteria for this review (Additional file 2: Table
S2). Two were based in the UK [33, 34] and one each in
Sweden [35], Italy [36], and the USA [9]. A further eligible
RCT is on-going [37]. Characteristics of the RCTs and risk
of bias assessments are described in Additional file 2. All
the RCTs used adequate random sequence generation
techniques and were judged to be at low risk of attrition
bias as loss to follow-up was low. However, no RCT
sought to blind patients, personnel, or outcome assessors.
Observational “real world” data
There were 143,871 patients with displaced intracapsular
hip fractures that underwent HA or THA and could be
matched to a record within HES APC (Fig. 1). 28,099
(19.5%) satisfied the pre-specified inclusion criteria, i.e.
ASA < 2, AMTS > 8, and independently mobile. The
groups initially varied considerably in terms of baseline
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characteristics (Additional file 3). After propensity score
matching, 12,290 cases were selected for further analysis.
Table 1 shows that the baseline characteristics of the
matched groups were similar. The distribution of pro-
pensity scores was also improved after matching (Add-
itional file 3).
Primary outcomes
Dislocation
All five RCTs reported risk of dislocation. Although the
pooled effect estimate suggested higher risk of disloca-
tion amongst those undergoing THA, this was not sig-
nificant (THA 9/233 [3.9%] versus HA 2/234 [0.9%],
RR 2.77 [95% 0.81 to 9.48], Fig. 2). Within the propen-
sity score matched cohort, those undergoing THA were
significantly more likely to dislocate than those with
HA (1.6% versus 0.9%, X2 p < 0.001). This finding per-
sisted when adjusting for co-variables in a competing
risks regression model (THA sub-distribution hazard
ratio [SHR] 1.73, 95% CI 1.24 to 2.41, see Table 2).
Revision
All five RCTs reported risk of revision [9, 33–36].
The pooled effect estimate was initially in favour of
HA, although this association was not statistically sig-
nificant (HA 8/234 [3.4%] versus 15/233 [6.4%], RR
1.52 [95% CI 0.56 to 4.14], Fig. 3). The association
also diminished when the data reported by Cadossi et
al. [36] were excluded as these authors had trialled a
non-standard THA prosthesis and reported an un-
usually high revision rate (HA 8/193 [4.1%] versus 9/
186 [4.8%], RR 1.16 [95% CI 0.46 to 2.91]). However,
within the propensity score matched cohort, a greater
proportion of HA patients underwent revision surgery
within the subsequent 12 months than THA (1.7%
versus 1.1%, X2 p < 0.001). This finding persisted
Fig. 1 A flow diagram showing inclusion of cases within the study
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when adjusting for co-variables in a competing risks re-
gression model (THA SHR 0.66, 95% CI 0.48 to 0.90).
Mortality
Four RCTs reported mortality at 12months and one at 6
months. A higher proportion of patients undergoing HA
died (36/234, 15.4%) than those in the THA group
(21/233, 9.0%, RR 0.63, 95% CI 0.38 to 1.04, Fig. 4). Within
the propensity score matched cohort, 12-month mortality
was higher in the HA group (5.4% versus 2.6%, X2
p < 0.001) and this persisted within a multi-level flexible
parametric survival model (hazard ratio 0.45, 95% CI 0.37
to 0.54). Twelve-month mortality within the observational
cohort is illustrated by a Kaplan-Meier plot in Fig. 5.
Secondary outcomes
Time to surgery
Two RCTs [33, 36] (164 patients) reported no differ-
ence in time to surgery between THA and HA (THA
mean difference − 0.44 [95% CI − 0.93 to 0.05]).
Within the propensity score matched cohort, patients
underwent HA more promptly than THA (median
Table 1 Characteristics of the matched population
Hemiarthroplasty Total hip arthroplasty Total P
Agec 77 (72–81) 77 (73–81) 77 (73–81) 0.571a
Sexd
Male 1347 (21.9%) 1321 (21.5%) 2668 (21.7%)
Female 4798 (78.1%) 4824 (78.5%) 9622 (78.3%) 0.569b
ASAc 2 (2–2) 2 (2–2) 2 (2–2) 0.675a
Pre-injury mobilityd
Independently mobile 5308 (86.7%) 5326 (86.7%) 10,634 (86.7%)
Mobile indoors with one aid 837 (13.6%) 819 (13.3%) 1656 (13.5%) 0.634b
AMTSc 10 (10–10) 10 (10–10) 10 (10–10) 0.457a
Admission sourced
Own home 6071 (98.8%) 6092 (99.1%) 12,163 (99.0%)
Rehabilitation unit 8 (0.1%) 2 (0.0%) 10 (0.1%)
Residential/nursing home 37 (0.6%) 18 (0.3%) 55 (0.5%)
Acute hospital 29 (0.5%) 33 (0.5%) 62 (0.5%) 0.015b
*Median (interquartile range); **number (percentage); aKruskall-Wallis one-way analysis of variance; bChi2 test
Table 2 Clinical outcomes for patients by operation
Hemiarthroplasty Total hip arthroplasty P
Primary outcomes
Dislocation (12 months) 57 (0.9%) 96 (1.6%) 0.002a
THA sub-distribution hazard ratio 1.73 (CI 1.24 to 2.41)b
Revision (12 months) 106 (1.7%) 67 (1.1%) < 0.001a
THA sub-distribution hazard ratio 0.66 (0.48 to 0.90)b
Mortality (12 months) 58 (5.5%) 159 (2.6%) < 0.001a
THA hazard ratio 0.45 (95% CI 0.37 to 0.54)c
Secondary outcomes
Surgical delay (hours)d 22.2 (17.8–29.0) 23.9 (18.9–40.6) < 0.001e
Length of stay (days)d 10 (7–15) 9 (7–13) < 0.001e
THA predicted mean difference − 1.92 (95% CI −2.30 to −1.55) daysf
Discharge home 5017 (80.7%) 5519 (88.6%) < 0.001a
THA adjusted odds ratio 1.77 (95% CI 1.58 to 1.99)g
Re-admission (30-days) 361 (5.9%) 356 (5.8%) 0.847a
THA adjusted odds ratio 0.96 (95% CI 0.82 to 1.11)g
aChi2 test; bCompeting risks regression model; cRoyston-Parmar flexible parametric model; dMedian (interquartile range); eKruskall-Wallis one-way analysis of
variance; fPredicted mean difference from a generalized linear model; gMultivariable logistic regression model
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22.2 [interquartile range (IQR) 17.8–29.0] hours ver-
sus 23.9, 18.9–40.6 h, Kruskall-Wallis p < 0.001).
Duration of surgery
All five RCTs (462 patients) reported surgical duration.
Although THA took longer than HA, and this difference
was statistically significant, the absolute effect was small
(mean difference 15.0 [95% CI 6.4 to 23.7] minutes).
Duration of surgery was not available from the propen-
sity score matched cohort.
Length of stay
Two RCTs (123 patients) reported length of stay and
there was no intervention effect on this outcome (THA
mean difference 1.50 [95% CI 0.00 to 3.00] days). In the
propensity score matched cohort, patients undergoing
HA stayed in hospital longer than those undergoing
THA (median 10 [IQR 7–15] versus 9 [7–13] days,
Kruskall-Wallis, p < 0.001). When adjusting for
co-variables within a generalised linear model, patients
undergoing THA experienced a shorter length of stay
(predicted mean difference − 1.92 [95% CI − 2.30 to −
1.55] days).
Discharge destination
No RCT reported discharge destination as an outcome.
Within the propensity score matched cohort, a smaller
proportion of patients undergoing HA were discharged
to their own home than THA (80.7% versus 88.6%, X2 p
< 0.001). Within a multivariable logistic regression
model, those undergoing THA also had higher odds of
being discharged to their own home (adjusted odds ratio
[aOR] 1.77, 95% CI 1.58 to 1.99).
30-day readmission
No RCT reported unplanned readmission to hospital as
an outcome. Within the propensity score matched co-
hort, there was no statistically significant difference in
30-day re-admission between the two groups (HA 5.9%
versus THA 5.8%, X2 p = 0.847), and this finding per-
sisted within a multivariable logistic regression model
(aOR 0.96, 95% CI 0.82 to 1.11).
Hip functional outcomes
All five RCTs reported joint-specific functional outcomes
measured at 12-months. Three studies used the Harris
Hip Score [9, 35, 36] (234 patients) and one each used
the Oxford Hip Score [33] (81 patients), Western On-
tario and McMaster Universities Osteoarthritis Index
(WOMAC) [9] (40 patients), and a bespoke hip ques-
tionnaire [34] (138 patients). Higher scores on all of
these measures reflect better outcomes except for the
Oxford Hip Score in which a higher score represents
worse function. There were no differences in terms of
total score (THA standardised mean difference [SMD]
0.17 [95% CI − 0.20 to 0.53]) or either the pain (− 0.01
Fig. 2 A forest plot showing risk of 12-month dislocation within eligible clinical trials
Fig. 3 A forest plot showing risk of 12-month revision within eligible clinical trials
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[− 0.49 to 0.48]) or function (0.18 [− 0.03 to 0.39]) do-
mains. The only study using the Oxford Hip Score re-
ported a difference between the groups in favour of
THA (THA mean difference − 3.50 [95% CI − 6.66 to −
0.34]). However, the only study reporting data from a
“Timed Up and Go” (TUG) test [9] (40 patients) –
which measures the time that it takes a patient to rise
from a chair, walk three metres, turn around, walk back
to the chair, and sit down – did not find a difference be-
tween the groups (THA mean difference − 0.70 [95% CI
− 8.01 to 6.61] seconds).
Health-related quality of life
Two studies [9, 33] (121 patients) reported components of
the Short Form (36) Health Survey (SF-36) and one the
EQ-5D [34] (183 patients). There were no differences in the
mental (THA mean difference 2.30 [95% CI − 8.57 to
13.18]) or physical (2.98 [− 0.89 to 6.85]) component
summary scores of the SF-36 or the EQ-5D (0.10 [0.00 to
0.20]) utility score.
Discussion
No previous meta-analysis has reported data limited to
the fittest patients with hip fractures, which are the pa-
tients that national guidelines recommend should be
considered for THA [2, 3]. This study identified five
RCTs that compared HA and THA amongst independ-
ently mobile older adults with displaced intracapsular
hip fractures [9, 33–36]. These trials were typically small
(median 89 patients) single-centre studies that were lim-
ited by few events (pooled totals 11/467 [2.4%] disloca-
tions, 23/467 [4.9%] revisions, and 57/467 [12.2%]
deaths). No individual trial reported differences in out-
comes and it is even possible that the pooled analyses
were underpowered to detect important differences be-
tween the groups. We therefore analysed data from the
largest available cohort of hip fracture patients and used
Fig. 4 A forest plot showing risk of 12-month mortality within eligible clinical trials
Fig. 5 Kaplan-Meier plot showing mortality for patients in the propensity score matched cohort
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propensity score matching to replicate randomisation as
far as is possible using observational data. The observa-
tional data confirmed the non-significant trend reported
by RCTs that THA has a higher risk of 12-month dis-
location. However, we found a 33% lower risk of
12-month revision for THA patients, which is contrary
to the RCT finding of “no difference” between the
groups observed in the RCTs.
Importantly, we identified a 58% lower risk of
12-month mortality for patients undergoing THA. Al-
though this may reflect residual confounding, a similar
association was evident from the meta-analysis of data
from all five trials. One possibility is that the increased
power available from the observational cohort has con-
firmed an association initially evident in the RCT data.
This finding would however need to be replicated in fur-
ther studies before it could be used to guide surgical
decisions.
We also presented data that has not previously been
reported by RCTs, including time to surgery, length of
stay, discharge destination, and 30-day re-admission.
Our study found that patients undergoing THA waited
longer for an operation (approximately 1.7 h), although
this delay is unlikely to be clinically significant. Although
the AAOS have expressed concern that increased
provision of THA might lead to operative delays [2], our
study suggests that hospitals in England are providing
THA within a timeframe that is comparable to HA. We
found that THA was associated with a shorter length of
stay (by approximately 1.9 days) and increased odds of
discharge home. However, there was no difference be-
tween the groups in terms of 30-day re-admission.
There was mixed evidence from the RCTs as to
whether or not functional outcomes or health-related
quality of life vary between the groups at 12-months.
The meta-analyses did not identify any statistically sig-
nificant differences, although one study reported signifi-
cantly better Oxford Hip Scores in the THA group [33].
There is however evidence to suggest that the functional
benefits of THA become more pronounced over a num-
ber of years follow-up [7].
There is one on-going RCT [37] that might – either in
isolation or when combined with data from previous tri-
als – report sufficient events to identify differences be-
tween the two operations. However, the AAOS has
expressed concern that the benefits of THA might not
be generalisable beyond the controlled environment of
clinical trials [2]. The RCTs identified in this study were
all based in large academic centres and two [35, 36] spe-
cified that operations were only performed by experi-
enced arthroplasty surgeons. Observational datasets can
provide important context for RCT findings as they re-
flect “real world” practice in which operations may also
be performed in smaller orthopaedic units, by generalist
orthopaedic surgeons, and by trainees. It is therefore re-
assuring that, although the propensity score matched co-
hort mirrored the RCT participants in terms of HA
dislocation rate (both 0.9%), the THA dislocation rate
was lower in the observational cohort than reported by
trials (1.6% versus 3.9%). There were also fewer revisions
identified in the propensity score matched cohort than
were reported by the RCTs (THA 1.1% versus 1.7%;
RCT 4.8% versus 4.1%). Although it is possible that
some dislocations and revision procedures were not cap-
tured by the linked dataset, our findings are similar to
those of a recent population-based study from Canada
[11]. These authors reported findings that were the same
in both magnitude and direction (THA dislocation 1.9%
versus 0.8%; revision 0.4% versus 2.3%) as observed in
our study. It is therefore possible that contemporary
prostheses perform better (in terms of major hip compli-
cations) than those used in trials undertaken between
2006 and 2013. Our findings do not support the hypoth-
esis that THAs undertaken outside RCTs are more
prone to dislocation and early revision.
Limitations
There are a number of limitations to our approach. First,
although extensive attempts were made to account for
case-mix differences within the cohort study, it is pos-
sible that some findings were subject to residual con-
founding, which would be expected to bias findings
against HA as surgeons are encouraged to reserve THA
for the fittest patients. However, it is important that a
similar signal was observed within the RCT data, which
should be much more resistant to confounding. Second,
as the NHFD was established to audit hip fracture care,
it does not collect some variables (e.g. surgical approach)
that might be found in a dedicated hip fracture registry.
Surgical approach is known to be associated with dis-
location [38] and this may be a further source of con-
founding. Third, coding errors are inevitable within the
NHFD and HES. However, the NHFD has almost
complete case capture and all re-admissions to hospitals
in England over the subsequent 12 months should have
been represented within HES. It is nevertheless possible
that some events will not have recorded within HES. Al-
though all arthroplasty revision procedures would have
been within the context of an inpatient admission, some
dislocations (e.g. those reduced and discharged home
directly from the Emergency Department) might not
have been captured by our study. Previous work in other
surgical settings has found that OPCS4 codes in HES
can reliably be used to identify some operations, al-
though this can vary substantially between procedures
[39]. However, a range of codes were used to define “re-
vision surgery” and this selection might have influenced
the findings. Nevertheless, our dislocation and revision
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rates were reassuringly similar to those reported by a re-
cent population-based study from Canada [11]. Finally,
there is evidence that the functional and health-related
quality of life benefits of THA only become apparent
after a number of years [7]. This study sought to com-
pare early complications and chose 12-month follow-up
as a means of directly comparing RCT findings with
those from a national cohort of comparable patients
with hip fractures. It is however possible that our
meta-analyses understated functional benefits of THA in
this population.
Conclusion
This study found that concerns about increased provision
of THA leading to clinically significant delays for older
adults with hip fractures are unfounded. Similarly, there
was not any evidence that dislocation or revision rates are
higher in England outside the context of clinical trials.
The finding of increased mortality amongst patients
undergoing HA requires urgent further study to deter-
mine whether or not this can be replicated in other bal-
anced populations.
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